Literature DB >> 2710139

Expression of three forms of thyroid hormone receptor in human tissues.

A Sakurai1, A Nakai, L J DeGroot.   

Abstract

At least two thyroid hormone receptor (hTR) genes are present in humans, but the significance of this multiplicity is unknown. These receptors could have differences in tissue distribution or possess different functions. We studied the distribution and abundance of three hTR mRNAs (hTR beta, hTR alpha 1, and hTR alpha 2) by Northern blot analysis. Three mRNAs were expressed in all tissues examined. hTR beta was strongly expressed in brain and prostate predominantly as a 10.0-kilobase (kb) mRNA. This mRNA was also expressed in thyroid and was much less abundant in liver, kidney, placenta, tonsil, and spleen. hTR alpha 1 is represented by two mRNAs with sizes of 6.0 and 3.2 kb. The 6.0-kb mRNA was constantly less abundant than the 3.2-kb mRNA. hTR alpha 2 was detected as a single mRNA with a size of 3.2 kb, using a probe unique for this mRNA. Both hTR alpha 1 and hTR alpha 2 were strongly expressed in brain, prostate, and thyroid and much less in other tissues. The relative amounts of the three hTR mRNAs were roughly parallel in each tissue. It is of interest that none of these hTRs was abundant in liver, which is the major thyroid hormone-responsive organ. Another hTR may be present in liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710139     DOI: 10.1210/mend-3-2-392

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  Regulatory functions of a non-ligand-binding thyroid hormone receptor isoform.

Authors:  T Hermann; X K Zhang; M Tzukerman; K N Wills; G Graupner; M Pfahl
Journal:  Cell Regul       Date:  1991-07

2.  Region-specific effects of hypothyroidism on the relative expression of thyroid hormone receptors in adult rat brain.

Authors:  Caterina Constantinou; Marigoula Margarity; Theony Valcana
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

Review 3.  The molecular basis of thyroid hormone action.

Authors:  L J DeGroot; A Nakai; A Sakurai; E Macchia
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

4.  Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.

Authors:  V K Chatterjee; T Nagaya; L D Madison; S Datta; A Rentoumis; J L Jameson
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor.

Authors:  F Zuo; R J Kraus; T Gulick; D D Moore; J E Mertz
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

Authors:  S J Usala; G E Tennyson; A E Bale; R W Lash; N Gesundheit; F E Wondisford; D Accili; P Hauser; B D Weintraub
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 7.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

8.  Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation.

Authors:  K Takeda; S Balzano; A Sakurai; L J DeGroot; S Refetoff
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Contrasting developmental and tissue-specific expression of alpha and beta thyroid hormone receptor genes.

Authors:  D Forrest; M Sjöberg; B Vennström
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

Review 10.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.